Valiant Laboratories Ltd
BSE: 543998
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 73.42+12.4% | 65.30+19.3% | 54.74+19.0% | 45.99-9.8% | 51.01-11.7% | 57.77+64.0% | 35.23+64.0% | 21.48 |
| Other Income | 0.85+10.3% | 0.77+27.7% | 0.61-28.4% | 0.85+26.0% | 0.67+2.7% | 0.65-1.8% | 0.67-65.6% | 1.93 |
| Total Income | 74.27+12.4% | 66.08+19.4% | 55.35+18.2% | 46.83-9.4% | 51.68-11.5% | 58.42+62.8% | 35.90+53.3% | 23.41 |
| EXPENSES | ||||||||
| Expenditure | 61.55+0.3% | 61.34+11.0% | 55.24+18.6% | 46.58-5.4% | 49.23-9.7% | 54.50+54.9% | 35.18+22.4% | 28.73 |
| Tax | 3.25+170.3% | 1.20+1475.5% | 0.08-16.3% | 0.09-85.5% | 0.63-8.1% | 0.69-22.2% | 0.88+32.7% | 0.66 |
| PROFIT | ||||||||
| PBT | 12.73+168.8% | 4.73+4232.0% | 0.11-57.6% | 0.26-89.5% | 2.45-37.7% | 3.92+445.7% | 0.72+113.5% | -5.32 |
| Net Profit | 9.48+168.3% | 3.53+10605.5% | 0.03-80.2% | 0.17-90.8% | 1.82-43.9% | 3.24+102.4% | 1.60+126.7% | -5.98 |
| KEY METRICS | ||||||||
| OPM % | 17.02%+10.13pp | 6.89%+6.43pp | 0.46%+0.33pp | 0.13%-4.50pp | 4.63%-2.00pp | 6.63%+8.10pp | -1.47%+34.68pp | -36.15% |
| NPM % | 12.76%+7.41pp | 5.35%+5.29pp | 0.06%-0.30pp | 0.36%-3.15pp | 3.51%-2.03pp | 5.54%+1.08pp | 4.46%+30.01pp | -25.55% |
| EPS | 1.75+169.2% | 0.65+6400.0% | 0.01-66.7% | 0.03-92.9% | 0.42-43.2% | 0.74+100.0% | 0.37+126.6% | -1.39 |
Corporate Events
Board MeetingVALIANTLAB
202628Sep
Board Meeting
The 5th Annual General Meeting ("AGM") is scheduled to be he…
BSE Filing ↗ Board MeetingVALIANTLAB
202617Sep
Board Meeting
The Board of Directors approved the proposed acquisition and…
BSE Filing ↗ Board MeetingVALIANTLAB
202610Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingVALIANTLAB
202412Nov
Board Meeting
Consider and approve Audited Standalone and Consolidated Fin…
BSE Filing ↗ Board MeetingVALIANTLAB
202412Aug
Board Meeting
Approval Of Standalone And Consolidated Audited Financial Re…
BSE Filing ↗ Board MeetingVALIANTLAB
202414May
Board Meeting
Consider and approve Standalone and Consolidated Audited Fin…
BSE Filing ↗